Clinical Trial Update: Calcitriol and Zoledronate in Treating Patients With Progressive Prostate Cancer [Phase 1]

View source ↗

Summary

A Phase 1 study evaluating the combination of Calcitriol and Zoledronate in patients with progressive prostate cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• Calcitriol (calcitriol)
• Zoledronate (zoledronic acid)

Snippet

Sponsor: Memorial Sloan Kettering Cancer Center | Conditions: Prostate Cancer | Phase 1 | Status: COMPLETED